Abstract
This study was concerned with the investigation of acute pharmacological responses (pharmacodynamics) including analgesic and anti-inflammatory effects of ketorolac tromethamine fast dissolving tablets prepared by direct compression method using 3% croscarmellose sodium as a superdisintegrant by applying tail flick test and carragenan induced rat paw edema test respectively. Also, the work aimed to develop a sensitive LC-MS/MS method for simultaneous determination of ketorolac tromethamine in human plasma samples released from fast dissolving tablets. Also, to estimate whether the prepared tablet dosage form increases the bioavailability of ketorolac tromethamine in the body compared to marketed conventional tablet. From this study, it could be inferred that ketorolac tromethamine fast dissolving tablets (G5) containing (3% corscarmellose sodium as a superdisintegrant, 30% Avicel pH102, 5% aspartame, 1% talc, 1% magnesium stearate, and mannitol Q.S.) and prepared by direct compression method could be considered as a promising formula to enhance bioavilability of the drug. Keyword: Ketorolac tromethamine fast dissolving tablet , Tail flick, Rat paw edema and bioavialbility
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
